
mTOR Inhibition Induces Compensatory, Therapeutically Targetable MEK Activation in Renal Cell Carcinoma
Author(s) -
Sean T. Bailey,
B. Zhou,
Jeffrey S. Damrauer,
Bhavani Krishnan,
Harper L. Wilson,
Aleisha M. Smith,
MingQing Li,
Jen Jen Yeh,
William Y. Kim
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/qcvm-v108
Subject(s) - pi3k/akt/mtor pathway , renal cell carcinoma , cancer research , discovery and development of mtor inhibitors , medicine , biology , microbiology and biotechnology , signal transduction